These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27775939)

  • 21. Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
    Chang CH; Wu HC; Tsai JJ; Shen YY; Changlai SP; Kao A
    Urol Int; 2003; 70(4):311-5. PubMed ID: 12740497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of
    Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
    Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
    Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
    Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG-PET for preoperative staging of bladder cancer.
    Drieskens O; Oyen R; Van Poppel H; Vankan Y; Flamen P; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1412-7. PubMed ID: 16133380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.
    Brunocilla E; Ceci F; Schiavina R; Castellucci P; Maffione AM; Cevenini M; Bianchi L; Borghesi M; Giunchi F; Fiorentino M; Chondrogiannis S; Colletti PM; Rubello D; Fanti S; Martorana G
    Clin Nucl Med; 2014 May; 39(5):e308-12. PubMed ID: 24458183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
    Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
    J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.
    Soubra A; Hayward D; Dahm P; Goldfarb R; Froehlich J; Jha G; Konety BR
    World J Urol; 2016 Sep; 34(9):1229-37. PubMed ID: 26847182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
    Lee HJ; Park JY; Lee JJ; Kim MH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2016 Mar; 140(3):409-14. PubMed ID: 26777990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
    Golan S; Sopov V; Baniel J; Groshar D
    J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.
    Jadvar H; Quan V; Henderson RW; Conti PS
    Int J Clin Oncol; 2008 Feb; 13(1):42-7. PubMed ID: 18307018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    van de Putte EEF; Vegt E; Mertens LS; Bruining A; Hendricksen K; van der Heijden MS; Horenblas S; van Rhijn BWG
    Int Urol Nephrol; 2017 Sep; 49(9):1585-1591. PubMed ID: 28674853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
    Lin SY; Tsai CS; Chang YC; Ng KK; Chang TC; Kao WH; Lai CH; Hong JH
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):577-85. PubMed ID: 25936817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer.
    Mertens LS; Fioole-Bruining A; van Rhijn BW; Kerst JM; Bergman AM; Vogel WV; Vegt E; Horenblas S
    J Urol; 2013 May; 189(5):1687-91. PubMed ID: 23142689
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Salminen A; Jambor I; Merisaari H; Ettala O; Virtanen J; Koskinen I; Veskimae E; Sairanen J; Taimen P; Kemppainen J; Minn H; Boström PJ
    Cancer Imaging; 2018 Aug; 18(1):25. PubMed ID: 30068379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.